Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with an advanced cancer that cannot be removed by surgery or has spread to other parts of the body, and your cancer has continued to grow despite your most recent standard treatment
- Your cancer is one of the following types: ovarian cancer, endometrial cancer (a specific subtype may need a particular gene change called CCNE1 amplification), stomach/esophageal cancer with CCNE1 amplification, small cell lung cancer, triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, or another solid tumor with CCNE1 amplification (confirm with trial site for full list)
- Depending on which part of the trial you are joining, you may need to have received a specific number of previous treatments — the exact number varies by cancer type, so confirm with the trial site
- For hormone receptor-positive/HER2-negative breast cancer: you must have previously received a CDK4/6 inhibitor and hormone therapy, and hormone therapy is no longer considered suitable for you
- Your liver, kidneys, and other organs are functioning well enough to participate (confirm with trial site)
- If you are able to become pregnant, you must be willing to use a highly effective form of birth control, or you are post-menopausal or have had surgery that means you cannot become pregnant
- You are able to swallow tablets or capsules
- You agree to provide a stored tumor tissue sample and a new tumor biopsy before starting treatment
Who may not be able to join:
- Your cancer could potentially be cured with surgery, radiation therapy, or chemotherapy
- You have a history of another cancer (some exceptions may apply — confirm with trial site)
- You have a history of certain rare immune system conditions affecting the lymph system or blood cells (confirm with trial site)
- You have not yet recovered from significant side effects of your previous cancer treatments
- You have had a serious heart or cardiovascular event (such as a heart attack or stroke) within the past 6 months
- You have active cancer that has spread to the brain or the lining around the brain
- You currently have active lung inflammation (interstitial lung disease) that requires treatment
- You have a history of eye conditions such as uveitis, retinopathy, or other significant eye or corneal problems
- You are still recovering from a major surgery within the past month, or a minor surgery within the past 10 days
- You have HIV, or an active hepatitis B or C infection
- You have previously been treated with a CDK2 inhibitor (a specific type of targeted cancer drug) — confirm with trial site if unsure
- You have moderate or severe liver cirrhosis or another significant liver condition
- You have received radiation therapy to relieve symptoms within the past 14 days, or any other radiation therapy within the past 4 weeks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with Dose Limiting Toxicity (DLT) events; Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.